Literature DB >> 6164697

Hypothesis: when is a seminoma not a seminoma?

D Raghavan, E Heyderman, P Monaghan, J Gibbs, E Ruoslahti, M J Peckham, A M Neville.   

Abstract

A xenograft line, HX 53, has been established in immune-suppressed mice from a specimen of a lymph node metastasis in a patient with a histological diagnosis of seminoma but with markedly raised circulating levels of alpha-fetoprotein. Histological, immunocytochemical, and ultrastructural studies of this xenograft line have suggested that a solid variant of yolk sac carcinoma may exist, which morphologically resembles seminoma, or that a continuum of differentiation exists between seminoma and yolk sac carcinoma.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6164697      PMCID: PMC1146437          DOI: 10.1136/jcp.34.2.123

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Testicular tumors; a clinicopathological study.

Authors:  F J DIXON; R A MOORE
Journal:  Cancer       Date:  1953-05       Impact factor: 6.860

Review 2.  Immunoperoxidase technique in histopathology: applications, methods, and controls.

Authors:  E Heyderman
Journal:  J Clin Pathol       Date:  1979-10       Impact factor: 3.411

3.  A shorter immunoperoxidase technique for the demonstration of carcinoembryonic antigen and other cell products.

Authors:  E Heyderman; A M Neville
Journal:  J Clin Pathol       Date:  1977-02       Impact factor: 3.411

4.  Yolk sac tumor associated with seminoma of the testis in adults.

Authors:  A Talerman
Journal:  Cancer       Date:  1974-05       Impact factor: 6.860

5.  Ultrastructure of human testicular tumors.

Authors:  G B Pierce
Journal:  Cancer       Date:  1966-12       Impact factor: 6.860

6.  Immunochromatography on insolubilized antibodies of very low affinity: application to immunoadsorbence of bovine alpha-fetoprotein.

Authors:  E Ruoslahti
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

7.  Anaplastic seminoma of the testis: ultrastructural analysis of three cases.

Authors:  M Janssen; W H Johnston
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860

8.  Improved immune-suppression techniques for the exongrafting of human tumours.

Authors:  G G Steel; V D Courtenay; A Y Rostom
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

9.  Serum alpha1-foetoprotein levels in 153 male patients with germ cell tumours.

Authors:  K M Grigor; S I Detre; J Kohn; A M Neville
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

  9 in total
  5 in total

1.  Advances in pathology and immunocytochemistry.

Authors:  E Heyderman
Journal:  J R Soc Med       Date:  1985       Impact factor: 5.344

2.  Features of squamous and adenocarcinoma in the same cell in a xenografted human transitional cell carcinoma: evidence of a common histogenesis?

Authors:  P J Russell; E J Wills; J Philips; J Wass; M Jelbart; P Gregory; D Raghavan
Journal:  Urol Res       Date:  1988

3.  The differential diagnosis of testicular germ cell tumors in theory and practice. A critical analysis of two major systems of classifiction and review of 389 cases.

Authors:  A R von Hochstetter; C E Hedinger
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982-08

Review 4.  Testicular germ cell tumours. Current problems of histogenesis and classification.

Authors:  F Kiss; J Juhász
Journal:  Int Urol Nephrol       Date:  1985       Impact factor: 2.370

Review 5.  The detection and evaluation of human tumor metastases.

Authors:  D J Laurence; A M Neville
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.